LYMEPOLICYWONK: Dr. Fallon Sets the Record Straight—Part 1. Size Matters.
Dr. Fallon, director of the Columbia Lyme Center, and colleagues have recently published an open access article (I’ll post the link below): “A reappraisal of the U.S. Clinical Trials of Post-Treatment Lyme Disease Syndrome.” The article reviews the findings of the four clinical trials and accurately lays out the state of the science in chronic Lyme research. This is important because future research needs and policy decisions are determined by the state of the science.
